Breast Cancer Health Models Stagnate in Validation Reporting Over Decade
A recent study highlights persistent shortcomings in the validation practices of model-based health economic evaluations for early breast cancer. Despite the introduction of new...
XLH Takes Toll on Families, Study Finds
Families supporting adults with X-linked hypophosphatemia (XLH) face significant challenges beyond the patients themselves. A recent study conducted in the United Kingdom highlights the...
Australian Newborn Screening for SMA Saves Millions and Enhances Infant Health
Australian healthcare systems are poised to benefit significantly from the implementation of newborn screening (NBS) for spinal muscular atrophy (SMA), offering both economic advantages...
Glofit-GemOx Fails Cost-Effectiveness Benchmark for Chinese DLBCL Patients
China's healthcare sector faces a crucial evaluation as a recent study reveals that the Glofitamab-based Glofit-GemOx regimen does not meet the cost-effectiveness standards for...
Medicare ACOs Deliver $4 Billion in Savings Over a Decade
Over the last ten years, Accountable Care Organizations (ACOs) within Medicare’s Shared Savings Program have made significant strides in reducing healthcare expenditures, benefiting both...
SGLT2 Inhibitors Reduce Hyperkalemia Risk in Patients Using RAAS Blockers
A recent comprehensive study conducted in Ontario has revealed that initiating sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients already prescribed renin-angiotensin-aldosterone system inhibitors (RAASi)...
Dr. Reddy’s to Distribute Sanofi’s Beyfortus® for RSV Prevention in India
In a significant move to combat respiratory syncytial virus (RSV) among infants, Dr. Reddy’s Laboratories Ltd. has partnered with Sanofi Healthcare India to launch...
PharmaMar Showcases Breakthrough Cancer Studies at AACR 2025
PharmaMar, a global frontrunner in marine-derived oncology treatments, made a significant impact at the 2025 Annual Meeting of the American Association for Cancer Research...
ZaZiBoNa Boosts Medicine Registration Efficiency in SADC Region
The Southern African Development Community's regulatory harmonization initiative, ZaZiBoNa, has made significant strides in enhancing the registration process for medicines over its first five...
Insufficient Info Leaves Glioblastoma Patients Unprepared for Chemoradiotherapy Toxicities
Navigating the tumultuous journey of glioblastoma treatment, patients and their caregivers face significant challenges beyond the clinical aspects, particularly concerning the side effects of...
Psychiatric Community Faces New Challenges in Globalized Neoliberal Era
As globalization and neoliberal pressures reshape societal structures, psychiatrists are grappling with increasingly intricate responsibilities, according to new research by George Ikkos and Nick...
New Group Boosts Ageing Research Impact Beyond Academia
Bridging the divide between academic research and real-world application, a pioneering special interest group has been established to advance ageing studies. This initiative aims...
Wales Launches Blueteq System to Oversee High-Cost Medications
Wales takes a significant step in healthcare management with the Phase II introduction of the Blueteq High Cost Drug System. This innovative web-based platform...
Bimzelx Gains EMA Approval to Combat Severe Inflammatory Diseases
The European Medicines Agency (EMA) has authorized Bimzelx, a groundbreaking monoclonal antibody treatment, for multiple severe inflammatory conditions. This approval marks a significant advancement...
British Columbia Discovers Diverse High-Cost Patient Categories
A recent population-based study in British Columbia has highlighted the varied cost patterns among high-need, high-cost (HNHC) patients, revealing critical insights for healthcare management...
